Precision Photonics Corporation proposes to develop and demonstrate the key technologies for a laser based multi-pathogen diagnostic system for HIV and common co-infections. The ultimate goal is to provide very low cost, easy to use tests at the point of care to help diagnose HIV and its co-infections in resource limited settings. The technology will use novel diode laser illumination and ultra-sensitive detection techniques with low cost optics and lasers, analogous to a DVD sensor head. By combining sensitive detection with an immunoassay format, reagent consumption is minimized. An array of detection spots and segregated tracers allow multi-analyte detection for multi-pathogen diagnosis. In the proposed project, we will (i) Establish a working, manufacturable reference design of the fluidic assay components and fluorescent reader. The cost/performance goals are to achieve a design that can meet a manufacturing cost of

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AI068543-02
Application #
7339017
Study Section
Special Emphasis Panel (ZRG1-AARR-E (16))
Program Officer
Fitzgibbon, Joseph E
Project Start
2006-01-15
Project End
2009-06-30
Budget Start
2007-07-15
Budget End
2008-06-30
Support Year
2
Fiscal Year
2007
Total Cost
$417,713
Indirect Cost
Name
Precision Photonics Corporation (PPC)
Department
Type
DUNS #
112617480
City
Boulder
State
CO
Country
United States
Zip Code
80301
Obermeit, Lisa C; Beltran, Jessica; Casaletto, Kaitlin B et al. (2017) Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining ""symptomatic"" versus ""asymptomatic"" HAND. J Neurovirol 23:67-78
Ma, Qing; Vaida, Florin; Wong, Jenna et al. (2016) Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol 22:170-8
Malvar, Jemily; Vaida, Florin; Sanders, Chelsea Fitzsimons et al. (2015) Predictors of new-onset distal neuropathic pain in HIV-infected individuals in the era of combination antiretroviral therapy. Pain 156:731-9
Grant, Igor; Franklin Jr, Donald R; Deutsch, Reena et al. (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82:2055-62
Lochhead, Michael J; Todorof, Kathryn; Delaney, Marie et al. (2011) Rapid multiplexed immunoassay for simultaneous serodiagnosis of HIV-1 and coinfections. J Clin Microbiol 49:3584-90
Heaton, R K; Clifford, D B; Franklin Jr, D R et al. (2010) HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 75:2087-96